Cardiovascular repair with bone marrow-derived cells

Woan Sang Kim, Sangho Lee, Young Sup Yoon

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

While bone marrow (BM)-derived cells have been comprehensively studied for their propitious pre-clinical results, clinical trials have shown controversial outcomes. Unlike previously acknowledged, more recent studies have now confirmed that humoral and paracrine effects are the key mechanisms for tissue regeneration and functional recovery, instead of transdifferentiation of BM-derived cells intocardiovascular tissues. The progression of the understanding of BM-derived cells has further led to exploring efficient methods to isolate and obtain, without mobilization, sufficient number of cell populations that would eventually have a higher therapeutic potential. As such, hematopoietic CD31+ cells, prevalent in both bone marrow and peripheral blood, have been discovered, in recent studies, to have angiogenic and vasculogenic activities and to show strong potential for therapeutic neovascularization in ischemic tissues. This article will discuss recent advancement on BM-derived cell therapy and the implication of newly discovered CD31+ cells.

Original languageEnglish
Pages (from-to)76-86
Number of pages11
JournalBlood Research
Volume48
Issue number2
DOIs
Publication statusPublished - 2013 Sep 23

Fingerprint

Bone Marrow Cells
Cell- and Tissue-Based Therapy
Regeneration
Cell Count
Bone Marrow
Clinical Trials
Therapeutics
Population

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Kim, Woan Sang ; Lee, Sangho ; Yoon, Young Sup. / Cardiovascular repair with bone marrow-derived cells. In: Blood Research. 2013 ; Vol. 48, No. 2. pp. 76-86.
@article{6bf79438726240679e9313c7a9e53797,
title = "Cardiovascular repair with bone marrow-derived cells",
abstract = "While bone marrow (BM)-derived cells have been comprehensively studied for their propitious pre-clinical results, clinical trials have shown controversial outcomes. Unlike previously acknowledged, more recent studies have now confirmed that humoral and paracrine effects are the key mechanisms for tissue regeneration and functional recovery, instead of transdifferentiation of BM-derived cells intocardiovascular tissues. The progression of the understanding of BM-derived cells has further led to exploring efficient methods to isolate and obtain, without mobilization, sufficient number of cell populations that would eventually have a higher therapeutic potential. As such, hematopoietic CD31+ cells, prevalent in both bone marrow and peripheral blood, have been discovered, in recent studies, to have angiogenic and vasculogenic activities and to show strong potential for therapeutic neovascularization in ischemic tissues. This article will discuss recent advancement on BM-derived cell therapy and the implication of newly discovered CD31+ cells.",
author = "Kim, {Woan Sang} and Sangho Lee and Yoon, {Young Sup}",
year = "2013",
month = "9",
day = "23",
doi = "10.5045/br.2013.48.2.76",
language = "English",
volume = "48",
pages = "76--86",
journal = "Blood Research",
issn = "2287-979X",
publisher = "Korean Society of Hematology",
number = "2",

}

Cardiovascular repair with bone marrow-derived cells. / Kim, Woan Sang; Lee, Sangho; Yoon, Young Sup.

In: Blood Research, Vol. 48, No. 2, 23.09.2013, p. 76-86.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Cardiovascular repair with bone marrow-derived cells

AU - Kim, Woan Sang

AU - Lee, Sangho

AU - Yoon, Young Sup

PY - 2013/9/23

Y1 - 2013/9/23

N2 - While bone marrow (BM)-derived cells have been comprehensively studied for their propitious pre-clinical results, clinical trials have shown controversial outcomes. Unlike previously acknowledged, more recent studies have now confirmed that humoral and paracrine effects are the key mechanisms for tissue regeneration and functional recovery, instead of transdifferentiation of BM-derived cells intocardiovascular tissues. The progression of the understanding of BM-derived cells has further led to exploring efficient methods to isolate and obtain, without mobilization, sufficient number of cell populations that would eventually have a higher therapeutic potential. As such, hematopoietic CD31+ cells, prevalent in both bone marrow and peripheral blood, have been discovered, in recent studies, to have angiogenic and vasculogenic activities and to show strong potential for therapeutic neovascularization in ischemic tissues. This article will discuss recent advancement on BM-derived cell therapy and the implication of newly discovered CD31+ cells.

AB - While bone marrow (BM)-derived cells have been comprehensively studied for their propitious pre-clinical results, clinical trials have shown controversial outcomes. Unlike previously acknowledged, more recent studies have now confirmed that humoral and paracrine effects are the key mechanisms for tissue regeneration and functional recovery, instead of transdifferentiation of BM-derived cells intocardiovascular tissues. The progression of the understanding of BM-derived cells has further led to exploring efficient methods to isolate and obtain, without mobilization, sufficient number of cell populations that would eventually have a higher therapeutic potential. As such, hematopoietic CD31+ cells, prevalent in both bone marrow and peripheral blood, have been discovered, in recent studies, to have angiogenic and vasculogenic activities and to show strong potential for therapeutic neovascularization in ischemic tissues. This article will discuss recent advancement on BM-derived cell therapy and the implication of newly discovered CD31+ cells.

UR - http://www.scopus.com/inward/record.url?scp=84884253295&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884253295&partnerID=8YFLogxK

U2 - 10.5045/br.2013.48.2.76

DO - 10.5045/br.2013.48.2.76

M3 - Review article

C2 - 23826576

AN - SCOPUS:84884253295

VL - 48

SP - 76

EP - 86

JO - Blood Research

JF - Blood Research

SN - 2287-979X

IS - 2

ER -